Sigma Kappa Foundation’s $1 million grant to the Alzheimer’s Association helps support the U.S. POINTER study. To date, Sigma Kappa has raised $264,311. U.S. POINTER is ground breaking in that it isn’t researching pharmaceutical intervention; this two-year clinical trial evaluates whether adopting a healthy lifestyle delays or prevents the onset of Alzheimer’s in high-risk populations
Support our team for the Alzheimer's Association Walk to End Alzheimer's®, the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research.
0
We have raised
1000
Our Goal
Search for Team Members
To find a team member, start typing their name below.
National Team
